Request for Information on the Bioeconomy, 47561-47562 [2019-19470]

Download as PDF khammond on DSKBBV9HB2PROD with NOTICES Federal Register / Vol. 84, No. 175 / Tuesday, September 10, 2019 / Notices pursuant to an Order of the Commission or the presiding officer. If you do not have an NRC-issued digital ID certificate as described above, click ‘‘Cancel’’ when the link requests certificates and you will be automatically directed to the NRC’s electronic hearing dockets where you will be able to access any publicly available documents in a particular hearing docket. Participants are requested not to include personal privacy information, such as social security numbers, home addresses, or personal phone numbers in their filings, unless an NRC regulation or other law requires submission of such information. For example, in some instances, individuals provide home addresses in order to demonstrate proximity to a facility or site. With respect to copyrighted works, except for limited excerpts that serve the purpose of the adjudicatory filings and would constitute a Fair Use application, participants are requested not to include copyrighted materials in their submission. The Commission will issue a notice or Order granting or denying a hearing request or intervention petition, designating the issues for any hearing that will be held and designating the Presiding Officer. A notice granting a hearing will be published in the Federal Register and served on the parties to the hearing. If a person (other than Justin Roberts) requests a hearing, that person shall set forth with particularity the manner in which his interest is adversely affected by this Order and shall address the criteria set forth in 10 CFR 2.309(d) and (f). If a hearing is requested by a person whose interest is adversely affected, the Commission will issue an Order designating the time and place of any hearings. If a hearing is held, the issue to be considered at such hearing shall be whether this Order should be sustained. In the absence of any request for hearing, or written approval of an extension of time in which to request a hearing, the provisions specified in Section IV above shall be final thirty (30) calendar days from the date of issuance of this Order without further order or proceedings. If an extension of time for requesting a hearing has been approved, the provisions specified in Section IV shall be final when the extension expires if a hearing request has not been received. For the Nuclear Regulatory Commission. George A. Wilson, Director, Office of Enforcement. VerDate Sep<11>2014 16:56 Sep 09, 2019 Jkt 247001 Dated this 5th day of September, 2019. [FR Doc. 2019–19556 Filed 9–9–19; 8:45 am] BILLING CODE 7590–01–P OFFICE OF SCIENCE AND TECHNOLOGY POLICY Request for Information on the Bioeconomy Office of Science and Technology Policy (OSTP). ACTION: Notice of request for information (RFI) for Bioeconomy. AGENCY: The Office of Science Technology and Policy (OSTP) requests input from all interested parties on the U.S. Bioeconomy. The Bioeconomy represents the infrastructure, innovation, products, technology, and data derived from biologically-related processes and science that drive economic growth, promote health, and increase public benefit. Through this Request for Information (RFI), OSTP seeks input from the public, including those with capital investments, performing innovative research, or developing enabling platforms and applications in the field of biological sciences, to include healthcare, medicine, pharmaceuticals, biotechnology, manufacturing, energy production, and agriculture. This RFI will inform notable gaps, vulnerabilities, and areas to promote and protect in the U.S. Bioeconomy that may benefit from Federal government attention. The information can include suggestions on those areas of greatest priority within the Bioeconomy, as well as past or future Federal government efforts to build, promote, and sustain the U.S. Bioeconomy. The public input provided in response to this RFI will inform the Executive Office of the President as well as private sector, academia, non-governmental entities, and other stakeholders with interest in and expertise relating to the promotion of a Bioeconomy ecosystem encompassing shared values and core American principles. DATES: Interested persons are invited to submit comments on or before 11:59 p.m. (ET) on October 22, 2019. ADDRESSES: Comments submitted in response to this notice may be submitted online to: MBX.OSTP.WHBioeconomy@ ostp.eop.gov. Email submissions should be machine-readable [pdf, word] and not be copy-protected. Submissions should include ‘‘RFI Response: Bioeconomy’’ in the subject line of the message. SUMMARY: PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 47561 Instructions: Response to this RFI is voluntary. Each individual or institution is requested to submit only one response. Submission must not exceed 10 pages in 12 point or larger font, with a page number provided on each page. Responses should include the name of the person(s) or organization(s) filing the comment. Comments containing references, studies, research, and other empirical data that are not widely published should include copies or electronic links of the referenced materials. Comments containing profanity, vulgarity, threats, or other inappropriate language or content will not be considered. Comments submitted in response to this notice are subject to FOIA. Responses to this RFI may also be posted, without change, on a Federal website. Therefore, we request that no business proprietary information, copyrighted information, or personally identifiable information be submitted in response to this RFI. In accordance with FAR 15–202(3), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Additionally, the U.S. Government will not pay for response preparation or for the use of any information contained in the response. FOR FURTHER INFORMATION CONTACT: Paige Waterman at: MBX.OSTP.WHBioeconomy@ ostp.eop.gov. SUPPLEMENTARY INFORMATION: A prosperous bioeconomy provides a host of opportunities for the current and future growth of all sectors of the U.S. economy. Today, the Bioeconomy ecosystem in the United States is a rapidly changing technological and economic environment. Data rights, analysis, use, storage and security are all critical components of biotechnology, healthcare, medicine, public health, data science, energy, environment, and agriculture. Ongoing research and innovation in these areas provide the foundation for solving the problems of today and the potentially unforeseen issues of tomorrow. To that end, stimulating the research enterprise, developing and sustaining workforce talent, and supporting the infrastructure for the manufacturing of products remain critical components to any Bioeconomy objective. To inform the Federal government’s decision-making and establish the Nation’s guiding values and principles in the promotion and protection of the U.S. Bioeconomy, OSTP seeks public input on how U.S. Government action regarding the Bioeconomy can support E:\FR\FM\10SEN1.SGM 10SEN1 khammond on DSKBBV9HB2PROD with NOTICES 47562 Federal Register / Vol. 84, No. 175 / Tuesday, September 10, 2019 / Notices scientific discovery, the development of technological advances, and increase the impact of a vibrant bioeconomy on the Nation’s vitality and our citizens’ lives. To that end, responders are specifically requested to answer one or more of the following questions in their submissions. Consortia responses are also encouraged. 1. What specific actions could the U.S. Government take to reinforce a values-based ecosystem that will guide the transformation and expansion of the U.S. Bioeconomy, in both the short- and long-term? Please consider: a. Policy or regulatory opportunities and gaps throughout the continuum of basic science translation, product development and commercialization; b. Scientific areas where research funding could be strategically targeted to stimulate discovery; c. Novel public-private partnership mechanisms; d. International opportunities; e. Challenges to taking identified actions or implementing change. 2. In what ways can the U.S. Government partner with the private sector, industry, professional organizations, and academia to ensure the training and continued development of a skilled workforce to support the growth of the Bioeconomy? Please consider: a. Potential needs and solutions at the skilled technical, undergraduate, professional master’s program or graduate level; b. Specific needs within basic science, translational research, product development, and commercialization; c. Approaches for the development of non-traditional, multi-disciplinary educational backgrounds that address the convergent nature of emerging technologies and integrate core values including safety and security; d. Effective geographic distribution of workforce and talent development across the United States; e. The development of a public and private ecosystem that will attract and retain domestic and foreign talent within the United States at all skill levels. 3. In what ways can the U.S. Government partner with the private sector, industry, professional organizations, and academia to establish a more robust and efficient Bioeconomy infrastructure? Please consider: a. Current infrastructure—from databases to world-class technology and manufacturing capabilities; b. Geographic distribution of manufacturing capabilities compared to future manufacturing needs; c. Leveraging existing public-private partnerships and identifying trusted VerDate Sep<11>2014 16:56 Sep 09, 2019 Jkt 247001 information sharing mechanisms to accelerate innovation and facilitate fruitful, equitable domestic and international collaborations; d. Institutional models for achieving translation of basic science discoveries to application and/or entry into the marketplace. 4. Across the spectrum, from basic discovery to practical application, what data policies, information-sharing mechanisms, and safeguards will be necessary for a prosperous U.S. Bioeconomy? Please consider: a. Scientific, regulatory, manufacturing standards and/or benchmarks and/or best practices around data that should be developed to best accelerate Bioeconomy growth; b. Possible safeguards for technology, data, and emergent products, such as patent/intellectual property protection, data quality and provenance validation, and privacy and security assurances. Sean Bonyun, Chief of Staff, Office of Science and Technology Policy. [FR Doc. 2019–19470 Filed 9–9–19; 8:45 am] BILLING CODE 3270–F9–P SECURITIES AND EXCHANGE COMMISSION [Investment Company Act Release No. 33616; File No. 812–14988] Diamond Hill Funds and Diamond Hill Capital Management, Inc. September 4, 2019. Securities and Exchange Commission (‘‘Commission’’). ACTION: Notice. AGENCY: Notice of an application for an order pursuant to: (a) Section 6(c) of the Investment Company Act of 1940 (‘‘Act’’) granting an exemption from sections 18(f) and 21(b) of the Act; (b) section 12(d)(1)(J) of the Act granting an exemption from section 12(d)(1) of the Act; (c) sections 6(c) and 17(b) of the Act granting an exemption from sections 17(a)(1), 17(a)(2) and 17(a)(3) of the Act; and (d) section 17(d) of the Act and rule 17d–1 under the Act to permit certain joint arrangements and transactions. Applicants request an order that would permit certain registered open-end management investment companies to participate in a joint lending and borrowing facility. APPLICANTS: Diamond Hill Funds, established as a business trust under the laws of Ohio and registered under the Act as an open-end management investment company with multiple series, and Diamond Hill Capital PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 Management, Inc. (the ‘‘Adviser’’), an Ohio corporation registered as an investment adviser under the Investment Advisers Act of 1940. FILING DATES: The application was filed on December 19, 2018, and amended on May 17, 2019. HEARING OR NOTIFICATION OF HEARING: An order granting the requested relief will be issued unless the Commission orders a hearing. Interested persons may request a hearing by writing to the Commission’s Secretary and serving applicants with a copy of the request, personally or by mail. Hearing requests should be received by the Commission by 5:30 p.m. on September 30, 2019 and should be accompanied by proof of service on the applicants, in the form of an affidavit, or, for lawyers, a certificate of service. Pursuant to Rule 0–5 under the Act, hearing requests should state the nature of the writer’s interest, any facts bearing upon the desirability of a hearing on the matter, the reason for the request, and the issues contested. Persons who wish to be notified of a hearing may request notification by writing to the Commission’s Secretary. ADDRESSES: Secretary, U.S. Securities and Exchange Commission, 100 F Street NE, Washington, DC 20549–1090; Applicants: Diamond Hill Funds and Diamond Hill Capital Management, Inc., 325 John H. McConnell Blvd., Suite 200, Columbus, Ohio 43215. FOR FURTHER INFORMATION CONTACT: Kieran G. Brown, Senior Counsel, at 202–551–6773, or David J. Marcinkus, Branch Chief, at (202) 551–6821 (Division of Investment Management, Chief Counsel’s Office). SUPPLEMENTARY INFORMATION: The following is a summary of the application. The complete application may be obtained via the Commission’s website by searching for the file number, or an applicant using the Company name box, at http:// www.sec.gov/search/search.htm or by calling (202) 551–8090. Summary of the Application 1. Applicants request an order that would permit the applicants to participate in an interfund lending facility where each Fund could lend money directly to and borrow money directly from other Funds to cover unanticipated cash shortfalls, such as unanticipated redemptions or trade fails.1 The Funds will not borrow under 1 Applicants request that the order apply to the applicants and to any other registered open-end management investment company or series thereof (each, a ‘‘Fund’’ and collectively, the ‘‘Funds’’) for which the Adviser or any successor-in-interest thereto or an investment adviser controlling, E:\FR\FM\10SEN1.SGM 10SEN1

Agencies

[Federal Register Volume 84, Number 175 (Tuesday, September 10, 2019)]
[Notices]
[Pages 47561-47562]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19470]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF SCIENCE AND TECHNOLOGY POLICY


Request for Information on the Bioeconomy

AGENCY: Office of Science and Technology Policy (OSTP).

ACTION: Notice of request for information (RFI) for Bioeconomy.

-----------------------------------------------------------------------

SUMMARY: The Office of Science Technology and Policy (OSTP) requests 
input from all interested parties on the U.S. Bioeconomy. The 
Bioeconomy represents the infrastructure, innovation, products, 
technology, and data derived from biologically-related processes and 
science that drive economic growth, promote health, and increase public 
benefit. Through this Request for Information (RFI), OSTP seeks input 
from the public, including those with capital investments, performing 
innovative research, or developing enabling platforms and applications 
in the field of biological sciences, to include healthcare, medicine, 
pharmaceuticals, biotechnology, manufacturing, energy production, and 
agriculture. This RFI will inform notable gaps, vulnerabilities, and 
areas to promote and protect in the U.S. Bioeconomy that may benefit 
from Federal government attention. The information can include 
suggestions on those areas of greatest priority within the Bioeconomy, 
as well as past or future Federal government efforts to build, promote, 
and sustain the U.S. Bioeconomy. The public input provided in response 
to this RFI will inform the Executive Office of the President as well 
as private sector, academia, non-governmental entities, and other 
stakeholders with interest in and expertise relating to the promotion 
of a Bioeconomy ecosystem encompassing shared values and core American 
principles.

DATES: Interested persons are invited to submit comments on or before 
11:59 p.m. (ET) on October 22, 2019.

ADDRESSES: Comments submitted in response to this notice may be 
submitted online to: [email protected]. Email 
submissions should be machine-readable [pdf, word] and not be copy-
protected. Submissions should include ``RFI Response: Bioeconomy'' in 
the subject line of the message.
    Instructions: Response to this RFI is voluntary. Each individual or 
institution is requested to submit only one response. Submission must 
not exceed 10 pages in 12 point or larger font, with a page number 
provided on each page. Responses should include the name of the 
person(s) or organization(s) filing the comment. Comments containing 
references, studies, research, and other empirical data that are not 
widely published should include copies or electronic links of the 
referenced materials. Comments containing profanity, vulgarity, 
threats, or other inappropriate language or content will not be 
considered.
    Comments submitted in response to this notice are subject to FOIA. 
Responses to this RFI may also be posted, without change, on a Federal 
website. Therefore, we request that no business proprietary 
information, copyrighted information, or personally identifiable 
information be submitted in response to this RFI.
    In accordance with FAR 15-202(3), responses to this notice are not 
offers and cannot be accepted by the Government to form a binding 
contract. Additionally, the U.S. Government will not pay for response 
preparation or for the use of any information contained in the 
response.

FOR FURTHER INFORMATION CONTACT: Paige Waterman at: 
[email protected].

SUPPLEMENTARY INFORMATION: A prosperous bioeconomy provides a host of 
opportunities for the current and future growth of all sectors of the 
U.S. economy. Today, the Bioeconomy ecosystem in the United States is a 
rapidly changing technological and economic environment. Data rights, 
analysis, use, storage and security are all critical components of 
biotechnology, healthcare, medicine, public health, data science, 
energy, environment, and agriculture. Ongoing research and innovation 
in these areas provide the foundation for solving the problems of today 
and the potentially unforeseen issues of tomorrow. To that end, 
stimulating the research enterprise, developing and sustaining 
workforce talent, and supporting the infrastructure for the 
manufacturing of products remain critical components to any Bioeconomy 
objective.
    To inform the Federal government's decision-making and establish 
the Nation's guiding values and principles in the promotion and 
protection of the U.S. Bioeconomy, OSTP seeks public input on how U.S. 
Government action regarding the Bioeconomy can support

[[Page 47562]]

scientific discovery, the development of technological advances, and 
increase the impact of a vibrant bioeconomy on the Nation's vitality 
and our citizens' lives. To that end, responders are specifically 
requested to answer one or more of the following questions in their 
submissions. Consortia responses are also encouraged.
    1. What specific actions could the U.S. Government take to 
reinforce a values-based ecosystem that will guide the transformation 
and expansion of the U.S. Bioeconomy, in both the short- and long-term? 
Please consider:
    a. Policy or regulatory opportunities and gaps throughout the 
continuum of basic science translation, product development and 
commercialization;
    b. Scientific areas where research funding could be strategically 
targeted to stimulate discovery;
    c. Novel public-private partnership mechanisms;
    d. International opportunities;
    e. Challenges to taking identified actions or implementing change.
    2. In what ways can the U.S. Government partner with the private 
sector, industry, professional organizations, and academia to ensure 
the training and continued development of a skilled workforce to 
support the growth of the Bioeconomy? Please consider:
    a. Potential needs and solutions at the skilled technical, 
undergraduate, professional master's program or graduate level;
    b. Specific needs within basic science, translational research, 
product development, and commercialization;
    c. Approaches for the development of non-traditional, multi-
disciplinary educational backgrounds that address the convergent nature 
of emerging technologies and integrate core values including safety and 
security;
    d. Effective geographic distribution of workforce and talent 
development across the United States;
    e. The development of a public and private ecosystem that will 
attract and retain domestic and foreign talent within the United States 
at all skill levels.
    3. In what ways can the U.S. Government partner with the private 
sector, industry, professional organizations, and academia to establish 
a more robust and efficient Bioeconomy infrastructure? Please consider:
    a. Current infrastructure--from databases to world-class technology 
and manufacturing capabilities;
    b. Geographic distribution of manufacturing capabilities compared 
to future manufacturing needs;
    c. Leveraging existing public-private partnerships and identifying 
trusted information sharing mechanisms to accelerate innovation and 
facilitate fruitful, equitable domestic and international 
collaborations;
    d. Institutional models for achieving translation of basic science 
discoveries to application and/or entry into the marketplace.
    4. Across the spectrum, from basic discovery to practical 
application, what data policies, information-sharing mechanisms, and 
safeguards will be necessary for a prosperous U.S. Bioeconomy? Please 
consider:
    a. Scientific, regulatory, manufacturing standards and/or 
benchmarks and/or best practices around data that should be developed 
to best accelerate Bioeconomy growth;
    b. Possible safeguards for technology, data, and emergent products, 
such as patent/intellectual property protection, data quality and 
provenance validation, and privacy and security assurances.

Sean Bonyun,
Chief of Staff, Office of Science and Technology Policy.
[FR Doc. 2019-19470 Filed 9-9-19; 8:45 am]
 BILLING CODE 3270-F9-P